Ever Supreme Bio Technology Co., Ltd (TPEX:6712)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
145.50
-4.50 (-3.00%)
At close: Mar 3, 2026

TPEX:6712 Ratios and Metrics

Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Mar '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
12,74514,15814,33815,02513,0139,856
Market Cap Growth
-13.18%-1.25%-4.57%15.46%32.03%8.98%
Enterprise Value
12,43213,52513,32413,88911,7649,488
Last Close Price
145.50154.82152.13154.52130.75109.32
PE Ratio
24.6938.5526.5874.8635.21-
Forward PE
25.0042.1741.0744.55--
PS Ratio
12.6715.1618.9123.9429.65139.61
PB Ratio
9.177.897.788.386.8612.62
P/TBV Ratio
9.267.947.838.446.9012.79
P/FCF Ratio
21.6932.5134.4747.5597.33-
P/OCF Ratio
21.6332.1534.0047.0795.90-
EV/Sales Ratio
12.3614.4817.5722.1326.81134.40
EV/EBITDA Ratio
23.6430.7237.2545.2083.16-
EV/EBIT Ratio
24.8232.1139.4548.94101.24-
EV/FCF Ratio
21.1531.0632.0443.9587.99-
Debt / Equity Ratio
0.030.000.000.010.020.06
Debt / EBITDA Ratio
0.090.010.020.060.23-
Debt / FCF Ratio
0.070.010.010.060.26-
Net Debt / Equity Ratio
-0.22-0.52-0.72-0.70-0.69-0.48
Net Debt / EBITDA Ratio
-0.67-2.12-3.72-4.07-9.262.74
Net Debt / FCF Ratio
-0.53-2.15-3.20-3.96-9.791.88
Asset Turnover
0.550.440.380.310.310.08
Inventory Turnover
3.153.673.482.944.193.52
Quick Ratio
1.453.466.208.2814.5810.73
Current Ratio
1.693.726.578.8915.2011.87
Return on Equity (ROE)
35.06%20.19%29.68%10.88%27.60%-13.13%
Return on Assets (ROA)
15.30%12.50%10.42%8.88%5.04%-11.10%
Return on Invested Capital (ROIC)
36.40%48.91%55.47%38.21%21.70%-45.10%
Return on Capital Employed (ROCE)
31.20%23.30%18.30%15.70%6.00%-19.20%
Earnings Yield
4.09%2.59%3.76%1.34%2.84%-1.08%
FCF Yield
4.61%3.08%2.90%2.10%1.03%-2.00%
Dividend Yield
3.10%3.01%3.26%0.97%2.61%-
Payout Ratio
78.29%119.82%25.27%154.19%--
Buyback Yield / Dilution
0.68%1.65%1.01%-0.15%-11.01%-0.09%
Total Shareholder Return
3.78%4.66%4.27%0.83%-8.40%-0.09%
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.